Search

everythinglearnresearchcommunity

for

Search:↓

In Brazil in 2018, the most common skin issues were acne, photoaging, and nonmelanoma skin cancer, with treatments often including topical medications and sunscreen.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Finasteride may help some women with hair loss, but better options exist.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

The leaves of Platycladus orientalis have potential health benefits but require more research for safety and understanding how they work.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

New psoriasis treatments are effective but come with side effects and risks.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

A drug called cimetidine can help treat hair loss in women by blocking androgen receptors. However, it's not the first choice and needs more research.

Lupus can cause hair loss and nail changes, with treatments available for both.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

The document explains different hair loss types and treatments, emphasizing diagnosis through examination and tests, and specific treatments for each condition.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Integrating best practices for steroid users in Swiss primary care is feasible and beneficial, but doping laws need change.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

A wearable cap-like device using light therapy reduced scalp skin lesions by 71% and was painless.

Up to 50% of scalp hair can be lost before it appears thin, and treatment is only needed for hair loss caused by diseases or deficiencies.

Treating both the mind and skin together, especially by managing stress, can greatly improve outcomes for skin disorders linked to psychological issues.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Primary health care in Florianópolis mostly treated simple skin conditions, while secondary care handled more complex skin diseases.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Many research paper titles in dermatology journals lack scientific precision.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.